2,3-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

CIS-4,7,10,13,16,19-DOCOSAHEXAENOIC ACID ETHYL ESTER, 95%, 100mg

2-Chloro-3-nitro-5-(trifluoromethyl)benzoic acid, 95.0%, 25g

Na-Benzyl-Na-methyl-L-alanine methyl ester hydrochloride, 99.0%, 1g

2-Methoxy-4-(6-nitro-1H-benzo[d]imidazol-2-yl)phenol, 97%, 100mg

5-(bromomethyl)-1-methyl-2-piperidinone, 95.0%, 1g

(4-Ethyloxan-4-yl)methanamine hydrochloride, 1g

2,4-Dichloro-3-fluorobromobenzene, 97.0%, 1g

tert-butyl 4-[(2Z)-2-(hydroxyimino)-2-(4-methoxyphenyl)ethyl]piperazine-1-carboxylate, 95.0%, 2g

1-(4-Methylphenyl)-2-thiourea, 98.0%, 100g

9H-Fuoroene-9-carboxylic acid, 95.0%, 100g

Éster bencílico del ácido benzoico, mínimo 99 %, para síntesis, 2,5 l, envase de vidrio

Methyl 2-(chlorosulfonyl)-5-nitrobenzoate, 97%, 1g